Iovance Biotherapeutics
IOVA
$13.45
Share price
0.45%
Change (1 day)
89.97%
Change (1 year)
Categories
Iovance Biotherapeutics (IOVA) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.19 B
According to Iovance Biotherapeutics 's latest financial reports the company's total liabilities are $0.19 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Iovance Biotherapeutics - Total liabilities on balance sheet (from 2008 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.19 B | 19.1% |
| 2022-12-31 | $0.16 B | 5.57% |
| 2021-12-31 | $0.15 B | 39.04% |
| 2020-12-31 | $0.11 B | 145.07% |
| 2019-12-31 | $45.68 M | 212.31% |
| 2018-12-31 | $14.62 M | 47.88% |
| 2017-12-31 | $9.89 M | 99.11% |
| 2016-12-31 | $4.96 M | 204.79% |
| 2015-12-31 | $1.63 M | -1.93% |
| 2014-12-31 | $1.66 M | -26.78% |
| 2013-12-31 | $2.26 M | -80% |
| 2012-12-31 | $11.34 M | -14.99% |
| 2011-12-31 | $13.34 M | 1522.3% |
| 2010-12-31 | $0.82 M | 3459.11% |
| 2009-12-31 | $0.02 M | 594.71% |
| 2008-12-31 | $0 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $3.14 M | -98.39% | Bahamas |
 NRC Health
NRC | $73.48 M | -62.46% | 🇺🇸 USA |